← back to search

Eva Strijbis

University of Alabama at Birmingham · US
Area of research
Pathology and Forensic Medicine · Neurology
Research interest
Research interests include Multiple sclerosis, Medicine, Psychology, Magnetic resonance imaging, Physical medicine and rehabilitation, and Proportional hazards model.
h-index
citations
233
works
15
NIH funding
primary concept
email

Recent publications

Advancing multiple sclerosis management in older adults
Nature Reviews Neurology 2025cited by 19position: middledoi
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome
JAMA Neurology 2025cited by 19position: middledoi
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis
Journal of Neurology Neurosurgery & Psychiatry 2025cited by 9position: middledoi
Measuring cognitive change in secondary progressive MS: an analysis of the ASCEND cognition substudy
Journal of Neurology 2025cited by 5position: middledoi
Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS study
Multiple Sclerosis Journal 2025cited by 3position: middledoi
Evaluation of machine learning-based classification of clinical impairment and prediction of clinical worsening in multiple sclerosis
Journal of Neurology 2024cited by 13position: middledoi
Utility of Progression Independent of Relapse Activity as a Trial Outcome in Relapsing-Remitting Multiple Sclerosis
Neurology 2024cited by 7position: firstdoi
More Than the Sum of Its Parts: Disrupted Core Periphery of Multiplex Brain Networks in Multiple Sclerosis
Human Brain Mapping 2024cited by 4position: middledoi
Conservation of structural brain connectivity in people with multiple sclerosis
Network Neuroscience 2024cited by 1position: middledoi
Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis
JAMA Neurology 2023cited by 63position: middledoi
Relapse recovery in relapsing–remitting multiple sclerosis: An analysis of the CombiRx dataset
Multiple Sclerosis Journal 2023cited by 14position: middledoi
Diffusion-based structural connectivity patterns of multiple sclerosis phenotypes
Journal of Neurology Neurosurgery & Psychiatry 2023cited by 12position: middledoi
The nine hole peg test as an outcome measure in progressive MS trials
Multiple Sclerosis and Related Disorders 2022cited by 13position: middledoi
Association of Age With Contrast-Enhancing Lesions Across the Multiple Sclerosis Disease Spectrum
Neurology 2021cited by 35position: middledoi
MRI brain volume loss, lesion burden, and clinical outcome in secondary progressive multiple sclerosis
Multiple Sclerosis Journal 2021cited by 16position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Gary Cutter · Epilepsy Foundation7 papers (2021–2025)Jop Mostert · University of Alabama at Birmingham7 papers (2021–2025)Marcus Koch · University of Calgary7 papers (2021–2025)James D. Bowen · Toronto Public Health6 papers (2021–2025)Pavle Repovic · University of Alabama at Birmingham6 papers (2021–2025)Jacynthe Comtois · Bausch Health (Canada)5 papers (2022–2025)Bernard M.J. Uitdehaag · Amsterdam University Medical Centers5 papers (2021–2025)Luís Brieva · Charité - Universitätsmedizin Berlin3 papers (2023–2025) · 3 papers (2023–2025)Fred Lublin · Icahn School of Medicine at Mount Sinai2 papers (2021–2023) · 2 papers (2024–2024)Victoria M. Leavitt · Columbia University2 papers (2025–2025)Jerry S. Wolinsky · The University of Texas Health Science Center2 papers (2021–2023)Amber Salter · Southwestern Medical Center1 papers (2024–2024)Claudia Chien · Humboldt-Universität zu Berlin1 papers (2024–2024) · 1 papers (2024–2024)Moritz Seiler · Humboldt-Universität zu Berlin1 papers (2024–2024)Robert J. Fox · Cleveland Clinic1 papers (2025–2025) · 1 papers (2024–2024) · 1 papers (2024–2024)